Начало › Остра лимфобластна левкемия › Тексас › Houston
Клинични проучвания за Остра лимфобластна левкемия в Houston, TX
28 проучвания за Остра лимфобластна левкемия търсят участници в обекти в и около Houston (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Набиране на участнициФаза 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Набиране на участнициНаблюдателно проучване
- Texas Children's Hospital, Houston
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Набиране на участнициФаза 1
- University of Texas MD Anderson Cancer Center, Houston
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Набиране на участнициФаза 2
- MD Anderson Cancer Center, Houston
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Набиране на участнициНаблюдателно проучване
- Texas Children's Hospital, Houston
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Набиране на участнициФаза 1/2
- MD Anderson Cancer Center, Houston
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Набиране на участнициФаза 1
- Texas Children's Hospital, Houston
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Набиране на участнициФаза 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Набиране на участнициФаза 2
- Baylor Texas Children's Hospital, Houston
A Study of CTD402 in T-ALL/LBL Patients
Набиране на участнициФаза 1/2
- MD Anderson Cancer Center, Houston
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Набиране на участнициНаблюдателно проучване
- Baylor College of Medicine Houston, Houston
Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
Набиране на участнициФаза 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Набиране на участнициФаза 2
- M D Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
Набиране на участнициФаза 2
- M D Anderson Cancer Center, Houston
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Набиране на участнициФаза 1/2
- Research Site, Houston
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Набиране на участнициФаза 1/2
- Research Site, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Набиране на участнициНаблюдателно проучване
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Study of Revumenib and Mezigdomide in People With Leukemia
Набиране на участнициФаза 1/2
- MD Anderson Cancer Center (Data Collection Only), Houston
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Набиране на участнициФаза 1/2
- MD Anderson, Houston
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Набиране на участнициФаза 2
- M D Anderson Cancer Center, Houston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Набиране на участнициНаблюдателно проучване
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Набиране на участнициФаза 1
- MD Anderson Cancer Center, Houston
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Набиране на участнициФаза 3
- Ascentage Investigative Site #1501, Houston
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Набиране на участнициФаза 1/2
- MDACC, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Набиране на участнициФаза 2
- MD Anderson, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Набиране на участнициФаза 1
- University of Texas MD Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Набиране на участнициФаза 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
Проучвания за Остра лимфобластна левкемия в други градове
- New York City, NY24 проучвания
- Baldwin Park, CA21 проучвания
- Seattle, WA21 проучвания
- Chicago, IL19 проучвания
- Atlanta, GA19 проучвания
- Philadelphia, PA16 проучвания
- Memphis, TN16 проучвания
- Washington, DC16 проучвания
- Boston, MA15 проучвания
- Los Angeles, CA14 проучвания
- Durham, NC13 проучвания
- Mountain View, CA13 проучвания
Други проучвания в Houston
- Рак на белия дроб с недребноклетъчен тип145 проучвания
- Рак на гърдата126 проучвания
- Рак (всички видове)121 проучвания
- Метастатичен рак104 проучвания
- Колоректален рак102 проучвания
- Рак на яйчниците89 проучвания
- Остра миелоидна левкемия85 проучвания
- Рак на белия дроб78 проучвания
- Рак на простатата76 проучвания
- Ендометриален рак68 проучвания
- Рак на панкреаса61 проучвания
- Меланом59 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.